부산대학교 도서관

Elghazaly H; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Azim HA; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt.; Rugo HS; Department of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, California, USA.; Cameron D; Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh and National Health Service Lothian, Edinburgh, UK.; Swain SM; Georgetown Lombardi Comprehensive Cancer Center, MedStar Health, Washington, District of Columbia, USA.; Curigliano G; Department of Oncology and Hemato-Oncology, European Institute of Oncology, IRCCS, University of Milano, Milan, Italy.; Harbeck N; Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, Breast Center, Ludwig Maximilian University Hospital, Munich, Germany.; Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Arun B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Aapro M; Breast Center, Clinique de Genolier, Genolier, Switzerland.; Piccart M; Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium.; Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.; Gligorov J; Medical Oncology Department, L'Assistance Publique-Hôpitaux de Paris, Institute Universitaire de Cancérologie, Sorbonne Université, Paris, France.; Elghazawy H; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; El Saghir NS; Division of Hematology Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.; Penault-Llorca F; National Institute of Health and Medical Research Unit 1240 'Molecular Imaging and Theranostic Strategies', Department of Pathology, Clermont Auvergne University, Center Jean Perrin, Clermont-Ferrand, France.; Perez EA; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA.; Poortmans P; Iridium Network and Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium.; Abdelaziz H; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; El-Zawahry HM; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt.; Kassem L; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Giza, Egypt.; Sabry M; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Viale G; European Institute of Oncology, IRCCS, Milan, Italy.; Al-Sukhun S; Al Hyatt Oncology Practice, Amman, Jordan.; Gado N; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Leung JWT; Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ezz Elarab L; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Cardoso MJ; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Faculdade de Medicina, Lisbon, Portugal.; Abdel Karim K; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Foheidi M; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Adult Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah, Saudi Arabia.; Elmaadawy MM; Diagnostic Radiology Department, Mansoura University, Mansoura, Egypt.; Conte P; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Division of Oncology, Istituto Oncologico Veneto-IRCCS, Padova, Italy.; Selim ASM; Diagnostic and Interventional Radiology Department, Cairo University, Giza, Egypt.; Kandil A; Department of Clinical Oncology, Alexandria School of Medicine, Alexandria, Egypt.; Kamal RM; Diagnostic and Interventional Radiology Department, Cairo University, Giza, Egypt.; Paltuev RM; Department of Breast Tumours of Federal State Budgetary Institution 'Petrov Research Institute of Oncology', Russian Association of Oncological Mammology, St Petersburg, Russia.; Guarneri V; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.; Division of Oncology, Istituto Oncologico Veneto-IRCCS, Padova, Italy.; Abulkhair O; Medical Oncology Department, Oncology Services, Alhabib Hospital, Riyad, Saudi Arabia.; Zakaria O; Department of Surgery, Cairo University, Cairo, Egypt.; Golshan M; Department of Surgery, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA.; Orecchia R; Scientific Directorate, IRCCS European Institute of Oncology, University of Milan, Milan, Italy.; ElMahdy M; Department of Pathology, Ain Shams University, Cairo, Egypt.; Abdel-Aziz AM; Department of Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.; Eldin NB; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Bidard FC; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; Department of Medical Oncology, Université de Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France.; Gligorov J; Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.; Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona; IOB Madrid, Hospital Beata Maria Ana, Madrid; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Oncoclínicas&Co, Jersey City, USA, Sao Paulo, Brazil.; Turner N; Breast Cancer Now Research Centre, Institute of Cancer Research, London; Ralph Lauren Centre for Breast Cancer Research and Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Dalenc F; Department of Medical Oncology, Oncopole Claudius Regaud-IUCT, Inserm, Toulouse.; Penault-Llorca F; Department of Pathology and Biopathology, Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR 1240 INSERM-UCA, Clermont-Ferrand.; Freyer G; Department of Medical Oncology, HCL Cancer Institute, Lyon; Department of Medical Oncology, Lyon 1 University, Lyon.; Arnedos M; Department of Medical Oncology Bordeaux, Institut Bergonié, Bordeaux.; Villanueva C; Clinique Clémentville, Montpellier, France.; Loibl S; Center for Hematology and Oncology Bethanien, Frankfurt, Germany.; Pistilli B; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.; Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Rüschoff J; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Penner A; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Ellis IO; Translational Medical Sciences, School of Medicine, The University of Nottingham, Department of Histopathology, City Hospital Campus, Nottingham University Hospitals, Nottingham, United Kingdom (Ellis).; Hammond MEH; Department of Pathology, Intermountain Healthcare and University of Utah School of Medicine, Salt Lake City (Hammond).; Lebeau A; University Medical Center Hamburg-Eppendorf, Institute of Pathology, Hamburg, Germany (Lebeau).; Private Group Practice for Pathology, Lübeck, Germany (Lebeau).; Osamura RY; Department of Diagnostic Pathology, Nippon Koukan Hospital, Kawasaki, Japan (Osamura).; Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France (Penault-Llorca).; Rojo F; Department of Pathology, IIS-Hospital Universitario Fundacion Jimenez Diaz-CIBERONC, Madrid, Spain (Rojo).; Desai C; Daiichi Sankyo, Basking Ridge, New Jersey (Desai, Moh).; Moh A; Daiichi Sankyo, Basking Ridge, New Jersey (Desai, Moh).; Atkey N; Diaceutics plc, Dataworks at Kings Hall Life Sciences Park, Belfast, County Antrim, United Kingdom (Atkey).; Baenfer G; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Scheel AH; Department of Pathology, University of Cologne, Cologne, Germany (Scheel).; D'Arrigo C; Poundbury Cancer Institute, Dorchester, United Kingdom (D'Arrigo).; Schildhaus HU; From the Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany (Rüschoff, Penner, Baenfer, Schildhaus).; Viale G; Department of Pathology, IEO European Institute of Oncology IRCCS Milan, Italy (Viale).

Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE

Cardoso F; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, and ABC Global Alliance, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.; Paluch-Shimon S; Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, Israel.; Schumacher-Wulf E; Mamma Mia, Kronberg, Germany.; Matos L; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal.; Gelmon K; BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada.; Aapro MS; Cancer Center, Clinique de Genolier, Genolier, Switzerland.; Bajpai J; Tata Memorial Centre, HBNI, Mumbai, India.; Barrios CH; Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil.; Bergh J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Bergsten-Nordström E; Europa Donna - the European Breast Cancer Coalition, Norrkoping, Sweden.; Biganzoli L; Department of Oncology, Hospital of Prato - Azienda USL Toscana Centro Prato, Italy and European Society of Breast Cancer Specialists (EUSOMA), Italy.; Cardoso MJ; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation and Lisbon University, Faculty of Medicine, Lisbon, Portugal.; Carey LA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.; Chavez-MacGregor M; Health Services Research, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, USA and American Society of Clinical Oncology (ASCO), Houston, USA.; Chidebe R; Project PINKBLUE, Abuja, Nigeria.; Cortés J; International Breast Cancer Center (IBCC), Madrid and Barcelona, Spain.; Curigliano G; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.; Dent RA; National Cancer Center Singapore, Singapore, Singapore.; El Saghir NS; NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.; Eniu A; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland and European School of Oncology (ESO), United Kingdom.; Fallowfield L; Brighton & Sussex Medical School, University of Sussex, Brighton, United Kingdom.; Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia.; Franco Millan SX; CTIC, Cancer Treatment and Research Center, Bogotá, Colombia.; Gilchrist J; Macquarie University, Sydney, Australia.; Gligorov J; Department of Medical Oncology, Cancer Est APHP Tenon, University Paris VI, Nice/St Paul Guidelines, Paris, France.; Gradishar WJ; Northwestern Medicine, Illinois, USA and National Comprehensive Cancer Network (NCCN), USA.; Haidinger R; Brustkrebs Deutschland e.V., Munich, Germany.; Harbeck N; Breast Centre, University of Munich, Munich and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany.; Hu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Kaur R; Breast Cancer Welfare Association, Petaling Jaya, Malaysia.; Kiely B; NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia.; Kim SB; Asan Medical Centre, Department of Oncology, Seoul, South Korea.; Koppikar S; Lilavati Hospital and Research Centre, Bombay Hospital Institute of Medical Sciences, Asian Cancer Institute, Mumbai, India.; Kuper-Hommel MJJ; Te Whatu Ora Waikato, Midland Regional Cancer Centre, NZ ABC Guidelines, Hamilton, New Zealand.; Lecouvet FE; Department of Radiology, Institut Roi Albert II and Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.; Mason G; Inflammatory Breast Cancer Research Foundation, West Lafayette, USA.; Mertz SA; MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, USA.; Mueller V; University Medical Center Hamburg-Eppendorf, Hamburg and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany.; Myerson C; Breast Cancer Now, London, United Kingdom.; Neciosup S; Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, ABC Latin America Guidelines, Peru.; Offersen BV; Department of Oncology, Aarhus University Hospital, Aarhus, European Society for Radiotherapy and Oncology (ESTRO), Denmark.; Ohno S; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.; Pagani O; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland.; Partridge AH; Dana-Farber Cancer Institute, Department of Medical Oncology and Division of Breast Oncology, Boston, USA and American Society of Clinical Oncology (ASCO), USA.; Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000, Clermont Ferrand, Nice/St Paul Guidelines, France.; Prat A; Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.; Rugo HS; Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.; Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.; Sledge GW; Division of Oncology, Stanford School of Medicine, Stanford, USA.; Swain SM; Georgetown University Lombardi Comprehensive Cancer Center and MedStar Health, Washington DC, USA.; Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale) and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany.; Vorobiof DA; Belong.Life, New York, USA.; Vuylsteke P; University of Botswana, Gaborone, Botswana and CHU UCL Namur Hospital, UCLouvain, Belgium.; Wiseman T; The Royal Marsden NHS Foundation Trust, University of Southampton, United Kingdom and European Oncology Nursing Society (EONS), United Kingdom.; Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Costa A; European School of Oncology, Milan, Italy and Bellinzona, Switzerland.; Norton L; Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, USA.; Winer EP; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Schostak M; Department of Urology, Urooncology, Robot-assisted and Focal Treatment, University Hospital Magdeburg, Magdeburg, Germany. Electronic address: martin.schostak@med.ovgu.de.; Bradbury A; Perelman Center for Advanced Medicine, Philadelphia, PA, USA.; Briganti A; Vita-Salute San Raffaele University, Milan, Italy.; Gonzalez D; Patrick G. Johnston Centre for Cancer Research, Queen's University, Belfast, UK.; Gomella L; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.; Penault-Llorca F; University Clermont Auvergne, Centre Jean Perrin, Clermont-Ferrand, France.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Wyatt AW; Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.; Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden; Department of Translational Medicine, Lund University, Lund, Sweden.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Giacchetti S; AP-HP, Hôpital Saint Louis, Senologie, Paris and Chronotherapy, Cancers, and Transplantation Unit, Faculty of Medicine, Paris-Saclay University, France; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France. Electronic address: sylvie.giacchetti@aphp.fr.; Laas E; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France.; Bachelot T; Medical Oncology, Centre Leon Berard, Lyon, France.; Lemonnier J; R&D Unicancer, Paris, France.; André F; Gustave Roussy, Villejuif, France.; Cameron D; ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Bliss J; Medical Oncology, Western General Hospital, Edinburgh, United Kingdom.; Chabaud S; Department of Clinical Research and Innovation, Centre Leon Berard, Lyon, France.; Hardy-Bessard AC; Medical Oncology, CARIO, Plerin, France.; Lacroix-Triki M; Gustave Roussy, Villejuif, France.; Canon JL; Medical Oncology, Grand Hopital de Charleroi, Charleroi, Belgium.; Debled M; Medical Oncology, Institut Bergonie, Bordeaux, France.; Campone M; Medical Oncology, Institut Cancerologie de l'Ouest, Saint Herblain, France.; Cottu P; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France.; Dalenc F; Medical Oncology, Oncopole Claudius Regaud, IUCT, Toulouse, France.; Ballesta A; U900, Institut Curie, Saint Cloud, France.; Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France.; Asselain B; Arcagy-Gineco, Paris, France.; Dumas E; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France; Department of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; (t)'Chronotherapy, Cancers, and Transplantation' Unit, Faculty of Medicine, Paris-Saclay University, Villejuif, France.; Reyal F; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France.; Gougis P; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France.; Lévi F; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France.; Hamy AS; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Ginzac A; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France. angeline.ginzac@clermont.unicancer.fr.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr.; Molnar I; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.; Durando X; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.; Motte Rouge T; Service d'oncologie médicale, Centre Eugène MARQUIS, Rennes, France.; Petit T; Service d'oncologie médicale, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; D'hondt V; Service d'oncologie médicale, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France.; Campone M; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France.; Bonichon-Lamichhane N; Service d'oncologie médicale et radiothérapie, Clinique Tivoli, Bordeaux, France.; Venat Bouvet L; Service d'oncologie médicale, CHU Dupuytren, Limoges, France.; Levy C; Service d'oncologie médicale, Centre François BACLESSE, Caen, France.; Augereau P; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France.; Pistilli B; Service d'oncologie médicale, Institut Gustave ROUSSY, Villejuif, France.; Arsene O; Service d'oncologie médicale, Centre Hospitalier de Blois, Blois, France.; Jouannaud C; Service d'oncologie médicale, Institut Jean GODINOT, Reims, France.; Nguyen S; Service d'oncologie médicale, Centre Hospitalier de Pau, Pau, France.; Cayre A; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France.; Tixier L; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France.; Mahier Ait Oukhatar C; Unicancer, Paris, France.; Nabholtz JM; Centre d'oncologie, Université King Saud (Medical City), Riyadh, Arabi Saoudite.; Penault-Llorca F; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France.; Mouret-Reynier MA; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Zhou K; Department of Human and Social Sciences, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.; Robert M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.; Seegers V; Department of Biostatistics, Institut de Cancérologie de l'Ouest, St-Herblain, France.; Blanc-Lapierre A; Department of Biostatistics, Institut de Cancérologie de l'Ouest, St-Herblain, France.; Savouroux S; Department of Health Promotion and Prevention, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.; Bigot F; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers, France.; Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.; Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.; Conroy T; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France.; Penault-Llorca F; Department of Biopathology and INSERM U1240, Centre Jean Perrin, Clermont-Ferrand, France.; Raoul JL; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.; Bellanger MM; Department of Human and Social Sciences, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.; Department of Health Promotion and Prevention, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Penault-Llorca F; Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR 1240 INSERM-UCA, Clermont Ferrand. Electronic address: Frederique.PENAULT-LLORCA@clermont.unicancer.fr.; Dalenc F; Oncopole Claudius Regaud, IUCT, Toulouse.; Chabaud S; Centre Léon Bérard, Lyon.; Cottu P; Institut Curie, Paris.; Allouache D; Centre François Baclesse, Caen, France.; Cameron D; Western General Hospital, Edinburg, UK.; Grenier J; Institut Sainte Catherine, Avignon.; Venat Bouvet L; CHU Dupuytren, Limoges, France.; Jegannathen A; Royal Stoke Hospital, Stoke-on-Trent, UK.; Campone M; Institut de cancérologie de l'Ouest, Saint-Herblain & Angers.; Debled M; Institut Bergonié, Bordeaux.; Hardy-Bessard AC; Centre CARIO-HPCA, Plérin.; Giacchetti S; APHP Hôpital Saint Louis, Paris.; Barthelemy P; Institut de Cancérologie Strasbourg Europe, Strasbourg.; Kaluzinski L; Centre Hospitalier Cotentin, Cherbourg en Cotentin.; Mailliez A; Centre Oscar Lambret, Lille.; Mouret-Reynier MA; Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR 1240 INSERM-UCA, Clermont Ferrand.; Legouffe E; Centre Oncogard, Nîmes.; Cayre A; Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR 1240 INSERM-UCA, Clermont Ferrand.; Martinez M; Clinique Pasteur, Toulouse.; Delbaldo C; Hôpital Diaconesses, Paris.; Mollon-Grange D; Hôpital Laennec, Quimper, France.; Macaskill EJ; Ninewells Hospital, Dundee.; Sephton M; Musgrove Park Hospital, Taunton, UK.; Stefani L; Centre Hospitalier Annecy, Pringy.; Belgadi B; Centre Hospitalier Montélimar, Montélimar, France.; Winter M; Weston Park Hospital, Sheffield, UK.; Orfeuvre H; Centre Hospitalier Fleyriat, Bourg-en-Bresse.; Lacroix-Triki M; Gustave Roussy, Villejuif, France.; Bonnefoi H; Institut Bergonié, Bordeaux.; Bliss J; The Institute of Cancer Research, London, UK.; Canon JL; Grand Hôpital de Charleroi, Charleroi, Belgium.; Lemonnier J; UNICANCER, Paris, France.; Andre F; Gustave Roussy, Villejuif, France.; Bachelot T; Centre Léon Bérard, Lyon.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Franchet C; Institut Universitaire du Cancer-Oncopole, Pathology Department, F-31059 Toulouse, France; Université Toulouse III-Paul Sabatier, F-31000 Toulouse, France. Electronic address: franchet.camille@iuct-oncopole.fr.; Schwob R; Thales Services Numériques, Augmented data department, F-31670 Labège, France.; Bataillon G; Institut Universitaire du Cancer-Oncopole, Pathology Department, F-31059 Toulouse, France.; Syrykh C; Institut Universitaire du Cancer-Oncopole, Pathology Department, F-31059 Toulouse, France.; Péricart S; Institut Universitaire du Cancer-Oncopole, Pathology Department, F-31059 Toulouse, France.; Frenois FX; Institut Universitaire du Cancer-Oncopole, Pathology Department, F-31059 Toulouse, France.; Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000 Clermont Ferrand, France.; Lacroix-Triki M; Département de Pathologie, Gustave-Roussy Cancer Campus, F-94805 Villejuif, France.; Arnould L; Department of Pathology and Tumor Biology, Centre Georges François Leclerc, Dijon, France.; Lemonnier J; R&D Unicancer, Paris, France.; Alliot JM; Institut de Recherche en Informatique de Toulouse, Toulouse University, Toulouse, France; CHU Toulouse, Toulouse, France.; Filleron T; Institut Universitaire du Cancer-Oncopole, Institut Claudius Regaud, Biostatistics & Health Data Science Unit, F-31059 Toulouse, France.; Brousset P; Institut Universitaire du Cancer-Oncopole, Pathology Department, F-31059 Toulouse, France; Université Toulouse III-Paul Sabatier, F-31000 Toulouse, France; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, UMR1037 CRCT, F-31037 Toulouse, France. Electronic address: brousset.pierre@iuct-oncopole.fr.

Publisher: Elsevier Country of Publication: United States NLM ID: 1250250 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0534 (Electronic) Linking ISSN: 00104825 NLM ISO Abbreviation: Comput Biol Med Subsets: MEDLINE